Instylla, developer of a blood-flow control system, has completed a $25.4m series B round featuring returning investor Ascension Ventures.

The OSU spinout plans to scale up the distribution of its robotics system, which has human-like legs to navigate complex environments.

Five years after being co-founded by UCL researchers, Ori Biotech has brought its overall funding to $41m.

The Allegion-backed hospitality platform developer has secured $30m in series B financing to take its funding to $50m over the past year.

MS&AD Ventures co-led a series A round disclosed as the enterprise AI software provider exited stealth mode.

Cancer drug developer ImmuneOnco has caught the attention of Eli Lilly's Asia-focused vehicle and will put the series B proceeds toward clinical trials.

Existing investor Intel Capital helped the computer vision software provider bring its funding to $33.5m to date.

DocuSign came on board as an investor in a series C round led by Y Combinator Continuity that lifted the digital mortgage software provider's total funding to at least $100m.

Corporates Walmart and Flipkart have renewed their commitment to the fresh produce distribution marketplace after initially striking up a strategic collaboration late last year.

Cisco, Microsoft and Citi all returned to lift cybersecurity technology provider Illusive Networks' total funding to $54m.